Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

The sebaceous gland has more roles than just producing sebum and contributing to acne, and new research could lead to better skin disease treatments.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Minoxidil causes excessive hair growth, but depilatory agent removes it safely and effectively.

Minoxidil controls blood pressure effectively, but may cause side effects like hypertrichosis.

Cinnamomi cortex may help treat prostate enlargement by reducing related proteins.

The skin is the largest organ, protecting the body, regulating temperature, and producing hormones.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

New compounds may soon be tested to treat excessive hair growth in women.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

The document reports the first Brazilian case of a girl with Becker nevus syndrome, characterized by skin changes, breast underdevelopment, and scoliosis.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Spironolactone may help reduce hair loss in androgenic alopecia.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Hair follicle stem cells are promising for wound healing but require more research for safe clinical use.

Combining cosmetic procedures with lifestyle changes improves antiaging results.